Extranodal localization of non-Hodgkin lymphoma in systemic sclerosis: A diagnostic challenge and review of the literature

被引:0
作者
Galoppini, Giorgio [1 ]
Maranini, Beatrice [1 ]
Ciancio, Giovanni [1 ]
Padovan, Melissa [1 ]
Casoni, Gian Luca [2 ]
Cavazzini, Francesco [3 ]
Gafa, Roberta [4 ]
Lanza, Giovanni [4 ]
Govoni, Marcello [1 ]
机构
[1] Univ Ferrara, Dept Med Sci, Rheumatol Unit, I-44121 Ferrara, Italy
[2] Hosp Rovigo, Pneumol Unit, Rovigo, Italy
[3] Univ Ferrara, Dept Med Sci, Hematol Unit, Ferrara, Italy
[4] Univ Ferrara, Dept Med Sci, Pathol Unit, Ferrara, Italy
关键词
Systemic sclerosis; hematological malignancies; splenic marginal zone lymphoma; B-cell lymphoma; MALT LYMPHOMA; RITUXIMAB;
D O I
10.1177/23971983221088459
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Systemic sclerosis is associated with an increased incidence of malignancies, in particular solid neoplasms. Hematological cancers have been also observed in autoimmune diseases, though rarely present with lung involvement. The latter may be misdiagnosed in systemic sclerosis patients, due to the frequent concomitant interstitial lung disease. Case description: Here, we present the case of a 63-year-old man affected by systemic sclerosis presenting with an atypical lung imaging and splenomegaly, who was diagnosed with splenic marginal zone lymphoma, thus raising the suspicion of lung secondarism. We discuss the diagnostic challenge of differential diagnosis in interstitial lung presentation and briefly review the available literature on this topic. Conclusion: Several reports have demonstrated an increased risk of malignancy in patients with systemic sclerosis. Still, the lack of concretely defined guidelines for systemic sclerosis, along with systemic sclerosis multifaceted organ involvement at presentation, may challenge diagnosis and management. Here, we remark the importance of clinical work-up and a multidisciplinary approach in systemic sclerosis, to early detect and treat concomitant hematological malignancies, especially during the first years of the disease.
引用
收藏
页码:NP1 / NP6
页数:6
相关论文
共 18 条
  • [1] [Anonymous], 2015, J CLIN EXP PATHOL
  • [2] Marginal zone B-Cell lymphoma of bronchus-associated lymphoid tissue
    Bae, Young A.
    Lee, Kyung Soo
    Han, Joungho
    Ko, Young-Hyeh
    Kim, Byung-Tae
    Chung, Myung Jin
    Kim, Tae Sung
    [J]. CHEST, 2008, 133 (02) : 433 - 440
  • [3] HRCT in primary pulmonary lymphoma: can CT imaging phenotypes differentiate histological subtypes between mucosa-associated lymphoid tissue (MALT) lymphoma and non-MALT lymphoma?
    Chen, Yinan
    Chen, Aiping
    Jiang, Hailin
    Zhang, Yuxuan
    Zhu, Lin
    Xia, Chunyan
    Yu, Hong
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (11) : 6040 - 6049
  • [4] Colaci M, 2017, Case Rep Rheumatol, V2017, P6230138, DOI 10.1155/2017/6230138
  • [5] Pulmonary MALT Lymphoma has variable features on CT
    Deng, Wen
    Wan, Ying
    Yu, Jian-qun
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [6] Systemic sclerosis
    Denton, Christopher P.
    Khanna, Dinesh
    [J]. LANCET, 2017, 390 (10103) : 1685 - 1699
  • [7] Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
    Goswami, Rudra P.
    Ray, Animesh
    Chatterjee, Moumita
    Mukherjee, Arindam
    Sircar, Geetabali
    Ghosh, Parasar
    [J]. RHEUMATOLOGY, 2021, 60 (02) : 557 - 567
  • [8] The radiological spectrum of pulmonary lymphoproliferative disease
    Hare, S. S.
    Souza, C. A.
    Bain, G.
    Seely, J. M.
    Gomes, M. M.
    Quigley, M.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2012, 85 (1015) : 848 - 864
  • [9] 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma
    Hoffmann, M
    Kletter, K
    Becherer, A
    Jäger, U
    Chott, A
    Raderer, M
    [J]. ONCOLOGY, 2003, 64 (04) : 336 - 340
  • [10] Rituximab A Review of its Use in Chronic Lymphocytic Leukaemia, Low-Grade or Follicular Lymphoma and Diffuse Large B-Cell Lymphoma
    Keating, Gillian M.
    [J]. DRUGS, 2010, 70 (11) : 1445 - 1476